Product Information
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1518 per EA under NDC 82009005401. Its NADAC has been published 146 times since Nov 8, 2023.
FDA first approved this application on May 12, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009005401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090509FDA Approved
5/12/2010
TE Code
AB
On Market Since
7/20/2023
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 25.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1518 per EA |
|---|---|
| All-time high | $0.2415 (Dec 13, 2023) |
| All-time low | $0.1513 (Jul 22, 2026) |
| 52-week high | $0.1729 |
| 52-week low | $0.1513 |
| Median price | $0.1729 |
| Average price | $0.1783 |
| Largest weekly change | +18.0% (Nov 22, 2023) |
| Weeks tracked | 146 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Quallent Pharmaceuticals Health LLC, is $0.1518 per EA (NDC 82009005401), effective Aug 19, 2026.
How has the price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has declined 25.8%. It has been tracked across 146 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 8, 2023, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1513 (Jul 22, 2026) to a high of $0.2415 (Dec 13, 2023), with a median of $0.1729 per EA.
Are there cheaper alternatives to TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) in a comparable dosage form, but none are currently priced below it.
Who manufactures TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) (NDC 82009005401) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.